Navigation Links
Vasomedical Announces Financial Results for the Fourth Quarter and Year Ended 2012
Date:4/1/2013

3,634Preferred stock dividends

$
-

$
-$
-

$  (1,459)Net (loss) income applicable to common stockholders

$
426

$  4,991$  (3,381)

$
2,175  BALANCE SHEETSDecember 31, 2012December 31, 2011(In thousands)Total current assets

$
25,716

$
27,686Total assets

$
32,381

$
34,335Total current liabilities

$
8,178

$
,508Total stockholders' equity

$
9,010

$
,276Except for historical information contained in this release, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this release, words such as "anticipates", "believes", "could", "estimates", "expects", "may", "plans", "potential" and "intends" and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of the Company's management, as well as assumptions made by and information currently available to the Company's management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the effect of the dramatic changes taking place in the healthcare environment; the impact of competitive procedures and products and their pricing; medical insurance reimbursement policies; unexpected manufacturing or supplier problems; unforeseen difficulties and delays in the conduct of clinical trials and other product development programs; the actions of regulatory authorities and third-party payers in the United States and overseas; uncertainties about the acceptance of a novel therapeutic modality by the medical community; continuation of the GEHC agreement; and the risk factors reported from time to time in the Company's SEC reports.  The Company undertakes no obligation to update forward-l
'/>"/>

SOURCE Vasomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Vasomedical to Report Fourth Quarter and Year End 2012 Results on April 1, 2013
2. Vasomedical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. Vasomedical, Inc. to Present Live Webcast at RetailInvestorConferences.com on February 7th
4. The International EECP Therapists Association and Vasomedical Announce Second Annual EECP Therapy Week
5. Vasomedical Common Stock Commences Trading on the OTCBB
6. Vasomedical Announces Financial Results for the Third Quarter of 2012
7. Vasomedical Named on Deloittes 2012 Technology Fast 500 List
8. Vasomedical Retains KCSA Strategic Communications as Corporate Communications Counsel
9. Cardiac Science announces definitive agreement to sell its Diagnostic Cardiology product line to Mortara Instrument, Inc.
10. BioLife Solutions Announces 2012 Full Year Results; 10th Consecutive Quarter of Record Revenue
11. Valeant Pharmaceuticals Announces Private Exchange Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , Mar. 26, 2015 Research and ... the addition of the "Marine Biotechnology - ... offering. Annual estimates and forecasts are ... a seven-year historic analysis is provided for these ... primary and secondary research. This report ...
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 /PRNewswire/ ... announced that Tom Cannell has joined ... for global commercialization of Contrave® /Mysimba™ (naltrexone HCl ... all aspects of Orexigen,s global commercial strategy, assuming ... After successfully leading Orexigen,s commercial effort through the ...
(Date:3/30/2015)... 30, 2015 NiQ Health, ... announced the high level interface capabilities of their ... systems. The partnership between CarePlus™ and ... this allows patients to choose the most appropriate ... acuity. The advanced functionality of CarePlus™ allows patient ...
Breaking Medicine Technology:Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2
... -- WuXi PharmaTech (NYSE: WX ), ... development outsourcing company, with operations in China and ... in a negotiated transaction agreed to purchase from ... Atlantic LLC ("General Atlantic") all of the WuXi ...
...  Mercy Jets has announced it will make contributions to ... of Heart Month, the  air ambulance  transportation and medical ... and heart-related health. While the  medical transport ... non-profit organizations, Mercy Jets will donate twice that amount ...
Cached Medicine Technology:WuXi PharmaTech Announces Purchase of Ordinary Shares from General Atlantic 2Mercy Jets Celebrates Heart Month With Charitable Donations 2
(Date:3/30/2015)... 2015 KIND LED’s suite of LED grow ... in 2015. The excellent value and product features of the ... pole position in the race for the best LED grow ... LED suite of grow lights is the 12 band ... Radiation (PAR) wavelengths that plants are most likely to use ...
(Date:3/30/2015)... Healtheminds, a start-up focusing on providing high quality ... to use and engaging online platform, is launching a ... related issues. The first in the series is a ... drugs. , Consumption and use of alcohol and ... toxic effects of excessive intake or drug overdoses, accidental ...
(Date:3/30/2015)... 30, 2015 Dr. Jeffrey Allred DDS, with ... 15 minute second opinion consultations for patients who ... statistics on dental second opinions show how small percentage of ... dental works. Only 6%” – says Dr. Allred. , ... when fully trusting the dental care provider, for the simple ...
(Date:3/30/2015)... 30, 2015 In its 2015 survey ... Robins & Morton sixth among the top general contractors ... Morton has specialized in healthcare construction for more than ... & Morton ranked on the list with $657 million ... company built 2.6 million square feet with 82 percent ...
(Date:3/30/2015)... York (PRWEB) March 30, 2015 A ... filed in California Superior Court on behalf of a ... birth defect after his mother was prescribed the anti-nausea ... the March 6th filing in Alameda Superior Court, the ... and vomiting that she experienced in the early months ...
Breaking Medicine News(10 mins):Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Modern Healthcare Ranks Robins & Morton No. 6 Contractor 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4
... that for people whose blood pressure do not lower //during ... ,In a healthy normal person blood pressure tends to lower ... sleep disturbances may elevate the nighttime blood pressures. ... levels of blood pressure at night may be the predictor ...
... have developed a blood test for early detection of ovarian ... killer as it is very difficult to diagnose during its ... cells of the ovaries, like the surface epithelial cells, germ ... in women is ranked 4th in terms of causing deaths ...
... of Public Health suggests that obesity can//increase the risk ... ,Obesity had been conclusively associated with increased risks ... of cancer. This is for the first time associations ... obese people lungs are under-expanded and size of the ...
... a diet// with low glycemic load will be much beneficial ... fat diet. ,A Glycemic index measures how the food ... their effect on the blood sugar level. The index ranges ... glucose level more than the others. These are the ones ...
... evidence that sheds new light on the details of how ... ,Huntington's disease is a genetic disorder that slowly destroys the ... own. Early symptoms of the disease may be depression, mood ... condition, the person is unable to take care of himself, ...
... to isolate a biomarker for prostate cancer cells do// that ... biomarker protein, which was hidden inside the cells, can now ... go into the blood. This will make it possible for ... both chemotherapy and immunotherapy, for better and more effective way ...
Cached Medicine News:
... VERSASTEP™ Plus Short Instrument ... , ,The VERSASTEP™ Plus ... Working Length is a unique ... applications in laparoscopic procedures. It ...
... Trocar consists of a blunt obturator connected ... assembly. , ,The valve body assembly ... to prevent gas leakage when instruments are ... Trocar includes built-in converters to allow insertion ...
... Premium One-Step™ single-use system device is comprised ... device components for creating each access port ... , Step™ insufflation and access needle, ... separately. , Step™ radially expandable sleeve, 100 ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
Medicine Products: